ImmunoGen (NASDAQ:IMGN)

Stock Price

Autohome, ImmunoGen Lead Friday’s 52-Week Low Club

July 15, 2016: Here are four stocks trading with relatively heavy volume among just 11 equities making new 52-week lows in Friday's session. Volumes only rose above 1 million for ...
Read Full Story »
Stock Price

ImmunoGen, CVR Top Thursday’s 52-Week Low Club

July 14, 2016: Here are four stocks trading with relatively heavy volume among just 13 equities making new 52-week lows in Thursday's session. Volumes did not rise about 1 million ...
Read Full Story »
Stock Price

CVR Refining, ImmunoGen Join Wednesday’s 52-Week Low Club

July 13, 2016: Here are four stocks trading with relatively heavy volume among 11 equities making new 52-week lows in Wednesday's session. NYSE decliners led advancers by a small margin ...
Read Full Story »
Stock Price

The 52-Week Low Club for Wednesday

June 15, 2016: Here are four stocks trading with relatively heavy volume among 28 equities making new 52-week lows in Wednesday's session. NYSE advancers led decliners by less than 2 ...
Read Full Story »
Stock Price

The 52-Week Low Club for Tuesday

June 14, 2016: Here are four stocks trading with relatively heavy volume among 97 equities making new 52-week lows in Tuesday's session. NYSE decliners led advancers by about 2 to ...
Read Full Story »
child with cancer

ASCO Could Make or Break These 7 Cancer Drug Trials

It is now getting close to the middle of May, and that means one thing for biotech investors. The king of biotech and pharma events is about to take place. ...
Read Full Story »
Stock Price

The 52-Week Low Club for Monday

May 2, 2016: Here are four stocks trading with relatively heavy volume among 24 equities making new 52-week lows in Monday's session. NYSE advancers led decliners by about 2 to ...
Read Full Story »
Stock Price

The 52-Week Low Club for Friday

April 29, 2016: Here are four stocks trading with relatively heavy volume among 28 equities making new 52-week lows in Friday's session. NYSE decliners led advancers by about 5 to ...
Read Full Story »
automatic inspection machine

4 Top Jefferies Biotech and Specialty Pharma Growth Stocks to Buy Now

With the market resuming full speed after the recent holiday, many investors are reviewing their portfolios for some final year-end changes in an attempt to grind out some 2015 gains. ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: AmEx, Carnival, eBay, HP, IAMGOLD, Pfizer, Tech Data and Many More

Stocks were indicated surprisingly higher after international markets recovered more than might have been expected. The trend that has been static for 4 years now is that investors want to ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Arch Coal, Autodesk, CarMax, Coach, ExxonMobil, Disney, Whiting and More

Stocks were looking for direction on Monday, with little news pulling the market one way or the other. A trend that is nearing four years old now is that investors ...
Read Full Story »
Biotechnology word cloud

How 6 ASCO Biotech Winners Are Focusing on the Future of Cancer

The American Society of Clinical Oncology (ASCO) had its annual meeting this past week. In this meeting, companies and cancer drug developers shared results from their most recent drug trials. ...
Read Full Story »
health care

6 Key Cancer Winners From ASCO Presentations

The American Society of Clinical Oncology, or ASCO, is currently having its annual meeting, in which companies and cancer drug developers share results from their most recent drug trials. The ...
Read Full Story »
Prescription drugs

The 5 Winners and Losers From ASCO Presentations

With the American Society of Clinical Oncology (ASCO) annual meeting just two weeks away, investors, doctors and cancer patients are anxiously awaiting some of the key presentations and abstracts that ...
Read Full Story »
95992888

5 Analyst Stock Picks Under $10 With Massive Upside Projections

The weak market of January was replaced by a first week of February that can only be described as one massive snapback rally. Investors have demonstrated for more than two ...
Read Full Story »